{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:16:23Z","timestamp":1773083783690,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T00:00:00Z","timestamp":1226620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s10072-008-1023-1","type":"journal-article","created":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T14:34:17Z","timestamp":1226673257000},"page":"417-423","source":"Crossref","is-referenced-by-count":21,"title":["Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer\u2019s disease and vascular dementia"],"prefix":"10.1007","volume":"29","author":[{"given":"Sabrina","family":"Ravaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Bini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Sinforiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Zardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Tosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo","family":"Moglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,14]]},"reference":[{"key":"1023_CR1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"C.P. Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C et al (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112\u20132117","journal-title":"Lancet"},{"key":"1023_CR2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G. McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of health and human services task force on Alzheimer\u2019s disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"1023_CR3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0166-2236(93)90078-Z","volume":"16","author":"M. Goedert","year":"1993","unstructured":"Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer\u2019s disease. Trends Neurosci 16:460\u2013465","journal-title":"Trends Neurosci"},{"key":"1023_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L. Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e L, Bussiere T, Bu\u00e9e-Scherrer V et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95\u2013130","journal-title":"Brain Res Rev"},{"key":"1023_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004010100423","volume":"103","author":"J.C. Augustinack","year":"2002","unstructured":"Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phophorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease. Acta Neuropathol 103:26\u201335","journal-title":"Acta Neuropathol"},{"issue":"[Suppl179]","key":"1023_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0404.107.s179.9.x","volume":"107","author":"N. Andreasen","year":"2003","unstructured":"Andreasen N, Vanmechelen E, Vanderstichele H et al (2003) Cerebrospinal fluid levels of total-Tau, phospho-Tau and A 42 predicts development of Alzheimer\u2019s disease in patients with mild cognitive impairment. Acta Neurol Scand 107[Suppl 179]:47\u201351","journal-title":"Acta Neurol Scand"},{"key":"1023_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clineuro.2004.10.011","volume":"107","author":"N. Andreasen","year":"2005","unstructured":"Andreasen N, Blennow K (2005) CSF biomarkers for mild cognitive impairment and early Alzheimer\u2019s disease. Clin Neurol Neurosurg 107:165\u2013173","journal-title":"Clin Neurol Neurosurg"},{"key":"1023_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K. Blennow","year":"1995","unstructured":"Blennow K, Wallin A, \u00c5gren H et al (1995) Tau protein in cerebrospinal fluid: a biochemical diagnostic marker for axonal degeneration in Alzheimer\u2019s disease? Mol Chem Neuropathol 26:231\u2013245","journal-title":"Mol Chem Neuropathol"},{"key":"1023_CR9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F. Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A et al (1999) Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology 52:1555\u20131562","journal-title":"Neurology"},{"key":"1023_CR10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N. Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P et al (1999) Cerebrospinal fluid -amyloid(1\u201342) in Alzheimer\u2019s disease: differences between early- and late-onset alzheimer disease and stability during the course of disease. Arch Neurol 56:673\u2013680","journal-title":"Arch Neurol"},{"key":"1023_CR11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M. Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H et al (1997) Elevated levels of tauprotein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225:210\u2013212","journal-title":"Neurosci Lett"},{"key":"1023_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K. Blennow","year":"2003","unstructured":"Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol 2:605\u2013613","journal-title":"Lancet Neurol"},{"key":"1023_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","volume":"61","author":"H. Hampel","year":"2004","unstructured":"Hampel H, Buerger K, Zinkoswski R et al (2004) Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer\u2019s Disease: a comparative cerebrospinal fluid study. Arch Gen Psychiatry 61:95\u2013102","journal-title":"Arch Gen Psychiatry"},{"key":"1023_CR14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000115975","volume":"25","author":"M. Bibl","year":"2008","unstructured":"Bibl M, Mollenhauer B, Esselmann H et al (2008) Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review. Dement Geriatr Cogn Disord 25:256\u2013265","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1023_CR15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"G.C. Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjuntti T et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250\u2013260","journal-title":"Neurology"},{"key":"1023_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"M.E. Folstein","year":"1975","unstructured":"Folstein ME, Folstein SE, McHugh PR (1975) Mini-mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189\u2013198","journal-title":"J Psychiatry Res"},{"key":"1023_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","volume":"37","author":"G. Tibbling","year":"1977","unstructured":"Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. Establishment of reference values. Scand J Clin Lab Investig 37:385\u2013390","journal-title":"Scand J Clin Lab Investig"},{"key":"1023_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E. Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P et al (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285:49\u201352","journal-title":"Neurosci Lett"},{"key":"1023_CR19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ana.1054","volume":"50","author":"N. Itoh","year":"2001","unstructured":"Itoh N, Arai H, Urakami K et al (2001) Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer\u2019s disease. Ann Neurol 50:150\u2013156","journal-title":"Ann Neurol"},{"key":"1023_CR20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","volume":"60","author":"A. Maddalena","year":"2003","unstructured":"Maddalena A, Papassotiropoulos A, Muller-Tillmanns B et al (2003) Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to betaamyloid peptide 42. Arch Neurol 60:1202\u20131206","journal-title":"Arch Neurol"},{"key":"1023_CR21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archneur.59.8.1267","volume":"59","author":"K. Buerger","year":"2002","unstructured":"Buerger K, Zinkowski R, Teipel SJ et al (2002) Differential diagnosis of Alzheimer\u2019s disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 59:1267\u20131272","journal-title":"Arch Neurol"},{"key":"1023_CR22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","volume":"70","author":"M. Sj\u00f6gren","year":"2001","unstructured":"Sj\u00f6gren M, Davidsson P, Tullberg M et al (2001) Both total and hyperphosphorylated tau are increased in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 70:624\u2013630","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1023_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s004010050418","volume":"91","author":"K.A. Jellinger","year":"1996","unstructured":"Jellinger KA (1996) Diagnostic accuracy of Alzheimer\u2019s disease. A clinicopathological study. Acta Neuropathol 91:219\u2013220","journal-title":"Acta Neuropathol"},{"key":"1023_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.174.1.45","volume":"174","author":"C. Holmes","year":"1999","unstructured":"Holmes C, Cairns N, Lantos P, Mann A (1999) Validity of current clinical criteria for Alzheimer\u2019s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174:45\u201350","journal-title":"Br J Psychiatry"},{"key":"1023_CR25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1532-5415.1999.tb02571.x","volume":"47","author":"A. Lim","year":"1999","unstructured":"Lim A, Tsuang D, Kukull W et al (1999) Clinico-neuropathological correlation of Alzheimer\u2019s disease in a community-based case series. J Am Geriatr Soc 47:564\u2013569","journal-title":"J Am Geriatr Soc"},{"key":"1023_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/JAD-2008-14110","volume":"14","author":"K.A. Jellinger","year":"2008","unstructured":"Jellinger KA (2008) The pathology of \u201cvascular dementia\u201d: a critical update. J Alzheimers Dis 14:107\u2013123","journal-title":"J Alzheimers Dis"},{"key":"1023_CR27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","volume":"56","author":"D.S. Knopman","year":"2001","unstructured":"Knopman DS, DeKosky ST, Cummings JL et al (2001) Practice parameter: diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1143\u20131153","journal-title":"Neurology"},{"key":"1023_CR28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3940(02)01483-0","volume":"339","author":"L. Walhund","year":"2003","unstructured":"Walhund L, Blennow K (2003) Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci Lett 339:99\u2013102","journal-title":"Neurosci Lett"},{"key":"1023_CR29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2005.07.003","volume":"3","author":"M.J. Leon De","year":"2006","unstructured":"De Leon MJ, Desanti S, Zinkowski R et al (2006) Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging 3:394\u2013401","journal-title":"Neurobiol Aging"},{"key":"1023_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000090631","volume":"3","author":"A.K. Wallin","year":"2006","unstructured":"Wallin AK, Blennow K, Andreasen N, Minthon L (2006) CSF biomarkers for Alzheimer\u2019s disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival. Dement Geriatr Cogn Disord 3:131\u2013138","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-1023-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-008-1023-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-1023-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:11:38Z","timestamp":1559121098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-008-1023-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,14]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1007\/s10072-008-1023-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,14]]}}}